CLARIFYing Coronary Heart Disease

Data will be collected and analysed at the Robertson Centre for Biostatistics, Glasgow, UK, under the guidance of Prof Ian Ford.

The registry will gather important information about the characteristics, management, outcomes and prognosis of CAD patients, with data collected prospectively at annual visits (12, 24, 36, 48 and 60 months). Patients will be evaluated not only on heart rate but also on their medical history, risk factors, and current chronic medical treatments to name a few criteria. The overall aim of CLARIFY is to identify:

  • The current profile of the CAD patient population, including demographics and clinical features
  • The current daily treatment practices in CAD and variations according to treatment setting and geography
  • The clinical outcomes and changing patterns in stable CAD management during the 5-year follow-up period
  • .

If you want to know more contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Share this article on your favourite social bookmarking sites:
Digg! Reddit! Del.icio.us! Google! Facebook! StumbleUpon! Twitter!